Search Results - "Jang, I J"
-
1
Selective enhancement of optical nonlinearity in two-dimensional organic-inorganic lead iodide perovskites
Published in Nature communications (29-09-2017)“…Reducing the dimensionality of three-dimensional hybrid metal halide perovskites can improve their optoelectronic properties. Here, we show that the…”
Get full text
Journal Article -
2
Safety, tolerability, pharmacodynamics and pharmacokinetics of DWP14012, a novel potassium‐competitive acid blocker, in healthy male subjects
Published in Alimentary pharmacology & therapeutics (01-07-2018)“…Summary Background A novel potassium‐competitive acid blocker, DWP14012, is in clinical development as a potential alternative to proton pump inhibitors for…”
Get full text
Journal Article -
3
Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance
Published in Clinical pharmacology and therapeutics (01-11-2013)“…This study aimed to evaluate endogenous metabolic markers of hepatic cytochrome P450 (CYP)3A activity in healthy subjects using a metabolomics approach…”
Get full text
Journal Article -
4
Targeted Next‐Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes
Published in Clinical pharmacology and therapeutics (01-03-2017)“…Phenotypic differences in drug responses have been associated with known pharmacogenomic loci, but many remain to be characterized. Therefore, we developed…”
Get full text
Journal Article -
5
Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans
Published in Diabetes, obesity & metabolism (01-01-2016)“…We hypothesized that the pharmacodynamic (PD) characteristics of metformin would change with inhibition of the multidrug and toxin extrusion (MATE)…”
Get full text
Journal Article -
6
Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects
Published in Journal of clinical pharmacy and therapeutics (01-12-2012)“…Summary What is known and Objective: Dexmedetomidine is a selective alpha2‐adrenoreceptor agonist used for sedation in critically ill patients. The current…”
Get full text
Journal Article -
7
Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations
Published in Clinical pharmacology and therapeutics (01-09-2008)“…Application of foreign clinical data across geographic regions can accelerate drug development. Drug disposition can be variable, and identification of factors…”
Get full text
Journal Article -
8
A novel K+ competitive acid blocker, YH4808, sustains inhibition of gastric acid secretion with a faster onset than esomeprazole: randomised clinical study in healthy volunteers
Published in Alimentary pharmacology & therapeutics (01-08-2017)“…Summary Background YH4808, a K+‐competitive acid blocker, is under clinical development for the treatment of acid‐related disorders, such as gastroesophageal…”
Get full text
Journal Article -
9
Near bandgap second-order nonlinear optical characteristics of MoS2 monolayer transferred on transparent substrates
Published in Applied physics letters (28-09-2015)“…We have investigated the second-order nonlinear optical (NLO) properties of CVD-grown MoS2 monolayer (ML) transferred onto transparent substrates such as fused…”
Get full text
Journal Article -
10
Aspirin Decreases Systemic Exposure to Clopidogrel Through Modulation of P-Glycoprotein But Does Not Alter Its Antithrombotic Activity
Published in Clinical pharmacology and therapeutics (01-06-2014)“…Decreased oral clopidogrel absorption caused by induction of intestinal permeability glycoprotein (P‐gp) expression after aspirin administration was observed…”
Get full text
Journal Article -
11
Publisher Correction: Selective enhancement of optical nonlinearity in two-dimensional organic-inorganic lead iodide perovskites
Published in Nature communications (23-11-2017)“…In the PDF version of this article, Eq. 5 is missing all elements after the equals sign. The correct version of Eq. 5 is given below. The HTML version of the…”
Get full text
Journal Article -
12
Pharmacokinetic and Pharmacodynamic Interaction of Lorazepam and Valproic Acid in Relation to UGT2B7 Genetic Polymorphism in Healthy Subjects
Published in Clinical pharmacology and therapeutics (01-04-2008)“…Pharmacokinetic and pharmacodynamic profiles of lorazepam and valproate were analyzed according to uridine 5′‐diphosphate‐glucuronosyltransferase (UGT)2B7…”
Get full text
Journal Article -
13
An Accelerator Mass Spectrometry‐Enabled Microtracer Study to Evaluate the First‐Pass Effect on the Absorption of YH4808
Published in Clinical pharmacology and therapeutics (01-09-2017)“…14C‐labeled YH4808, a novel potassium‐competitive acid blocker, was intravenously administered as a microtracer at 80 μg (11.8 kBq or 320 nCi) concomitantly…”
Get full text
Journal Article -
14
Pharmacodynamic comparison of two formulations of Acarbose 100-mg tablets
Published in Journal of clinical pharmacy and therapeutics (01-10-2012)“…Summary What is known and Objective: Acarbose, an α‐glycosidase inhibitor, is used to treat diabetic patients. Pharmacokinetic evaluation of acarbose is…”
Get full text
Journal Article -
15
Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects
Published in Journal of clinical pharmacy and therapeutics (01-08-2014)“…Summary What is known and objective Both metformin and acarbose are recommended monotherapy and add‐on therapy in type 2 diabetes mellitus (T2DM). A fixed‐dose…”
Get full text
Journal Article -
16
Frequency of CYP2C9 variant alleles, including CYP2C913 in a Korean population and effect on glimepiride pharmacokinetics
Published in Journal of clinical pharmacy and therapeutics (01-02-2012)“…Summary What is known and Objective: Cytochrome P450 (CYP) 2C9 is a clinically important enzyme involved in the metabolism of many drugs commonly used in…”
Get full text
Journal Article -
17
-
18
Exploration of Biomarkers for Amoxicillin/Clavulanate‐Induced Liver Injury: Multi‐Omics Approaches
Published in Clinical and translational science (01-05-2017)“…To explore potential biomarkers for amoxicillin/clavulanate‐induced liver injury (AC‐DILI), we conducted a clinical trial in 32 healthy subjects based on…”
Get full text
Journal Article -
19
Prolonged Use of Aspirin Alters Human and Rat Intestinal Cells and Thereby Limits the Absorption of Clopidogrel
Published in Clinical pharmacology and therapeutics (01-10-2011)“…Clopidogrel therapy to prevent atherothrombosis faces the challenge of reduced responsiveness. The absorption of clopidogrel is regulated by…”
Get full text
Journal Article -
20
Effect of multiple doses of fimasartan, an angiotensin II receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volunteers
Published in International journal of clinical pharmacology and therapeutics (01-05-2011)“…Fimasartan (BR-A-657) is an angiotensin II receptor antagonist, recently approved as an antihypertensive agent. This study aimed to investigate whether…”
Get full text
Journal Article